Access cutting-edge heparin-induced thrombocytopenia treatment through this clinical trial at a research site in Tucson. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Tucson location
Preparing your pre-screening questions…
Access heparin-induced thrombocytopenia specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related heparin-induced thrombocytopenia treatment provided free
Check if you qualify for this heparin-induced thrombocytopenia clinical trial in Tucson, AZ
No-Cost Study Care
Local to Tucson
Convenient for AZ residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The purpose of this research is to identify genomic markers that can predict heparin-induced thrombocytopenia (HIT), which is a very serious side effect to heparin. Heparin is commonly used to prevent blood clots and the investigators may be able to identify genomic markers which can be used to prevent heparin use in people who will get HIT.
Sponsor: University of Arizona
Yes, this clinical trial (NCT02717039) has an active research site in Tucson, AZ that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for heparin-induced thrombocytopenia treatment options in Tucson, AZ, this clinical trial (NCT02717039) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Tucson research site is actively enrolling participants for this clinical trial. You'll receive care from experienced heparin-induced thrombocytopenia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all heparin-induced thrombocytopenia clinical trials near you to find additional studies recruiting in your area.
See all pulmonary embolism clinical trials recruiting in Tucson — not just this study.
Browse Pulmonary Embolism Trials in Tucson →